Search research articles
Contact Us
Filters
Showing results (841-850 of 857) with videos related to
Page
of 86
Sort By:
Acta Neuropathologica
|
August 3, 2017
RNAi screen identifies essential regulators of human brain metastasis-initiating cells
Mohini Singh, Chitra Venugopal, Tomas Tokar, et al.
Nature Communications
|
June 7, 2024
Protein translation rate determines neocortical neuron fate
Ekaterina Borisova, Andrew G Newman, Marta Couce Iglesias, et al.
Journal of Neuroinflammation
|
April 24, 2025
A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis
Stefan Wendt, Ada J Lin, Sarah N Ebert, et al.
Journal of Medicinal Chemistry
|
December 20, 2017
Identification of [<sup>18</sup>F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging
Vadim Bernard-Gauthier, Andrew V Mossine, Anne Mahringer, et al.
Journal of Medicinal Chemistry
|
July 12, 2017
A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human
Vadim Bernard-Gauthier, Justin J Bailey, Andrew V Mossine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2010
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma
Olena Morozova, Milijana Vojvodic, Natalie Grinshtein, et al.
Obstetrics and Gynecology
|
October 8, 2021
Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol
Michelle Y Lu, Christina T Blanchard, Elizabeth B Ausbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group
G J Bubley, M Carducci, W Dahut, et al.
ESMO Open
|
January 31, 2025
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy
Z L R Kaplan, N van Leeuwen, D van Klaveren, et al.
British Journal of Cancer
|
April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
T S Maughan, A M Meade, R A Adams, et al.
Page
of 86
Search research articles
Search
Showing results (841-850 of 857) with videos related to
Sort By:
Page
of 86
Acta Neuropathologica
|
August 3, 2017
RNAi screen identifies essential regulators of human brain metastasis-initiating cells
Mohini Singh, Chitra Venugopal, Tomas Tokar, et al.
Nature Communications
|
June 7, 2024
Protein translation rate determines neocortical neuron fate
Ekaterina Borisova, Andrew G Newman, Marta Couce Iglesias, et al.
Journal of Neuroinflammation
|
April 24, 2025
A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis
Stefan Wendt, Ada J Lin, Sarah N Ebert, et al.
Journal of Medicinal Chemistry
|
December 20, 2017
Identification of [<sup>18</sup>F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging
Vadim Bernard-Gauthier, Andrew V Mossine, Anne Mahringer, et al.
Journal of Medicinal Chemistry
|
July 12, 2017
A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human
Vadim Bernard-Gauthier, Justin J Bailey, Andrew V Mossine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2010
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma
Olena Morozova, Milijana Vojvodic, Natalie Grinshtein, et al.
Obstetrics and Gynecology
|
October 8, 2021
Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol
Michelle Y Lu, Christina T Blanchard, Elizabeth B Ausbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group
G J Bubley, M Carducci, W Dahut, et al.
ESMO Open
|
January 31, 2025
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy
Z L R Kaplan, N van Leeuwen, D van Klaveren, et al.
British Journal of Cancer
|
April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
T S Maughan, A M Meade, R A Adams, et al.
Page
of 86